-
The Burden of Patients With Severe Asthma: A Comparison Between Patients Treated With and Eligible for Monoclonal Antibodies Through a Retrospective Observational Analysis of Italian Real-World Data
Sep 9, 2025, 16:22 PM -
Development of a Preliminary Conceptual Model to Capture the Adult Patient Experience of Follicular Lymphoma
Sep 9, 2025, 16:22 PM -
Epidemiological Study of Pulmonary Hypertension in Patients With Interstitial Lung Diseases (PH-ILD) in Greece: A Retrospective Multicenter Study
Sep 9, 2025, 16:22 PM -
When Less Is More? Learnings From a Recent NICE Submission Utilizing a Novel Predictive Individual-Level Surrogacy Approach to Predict Overall Survival (OS) in the Absence of Trial-Level Evidence
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Rozanolixizumab for the Treatment of Generalized Myasthenia Gravis (gMG) in Greece
Sep 9, 2025, 16:22 PM -
NICE Guidance, Not-So-NICE Realities: Resource Constraints in HTA
Sep 9, 2025, 16:22 PM -
Evolution and Geographical Patterns of the Portuguese Newborn Screening Program in the Last 10 Years
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization Associated With Acute Pancreatitis in Patients With Familial Chylomicronemia Syndrome Treated With Olezarsen: A Post Hoc Analysis of Balance Study Data
Sep 9, 2025, 16:22 PM -
Viable Rate of Return for Social Impact Bonds Supporting Research and Development of Gene Therapies for Rare Conditions
Sep 9, 2025, 16:22 PM -
Biomarker Levels in Patients With Ulcerative Colitis Post-Advanced Therapy Induction: A Real-World Survey in Europe
Sep 9, 2025, 16:22 PM -
A Systematic Review of Trends From Migraine Preference Studies
Sep 9, 2025, 16:22 PM -
Mapping to EQ-5D Utility in Knee Osteoarthritis: A Comparative Evaluation of WOMAC and SF-36 Algorithms in the STEP 9 Trial
Sep 9, 2025, 16:22 PM -
Evaluating the Cost-Effectiveness of Nasal Adrenaline Spray vs. Adrenaline Autoinjector for Treatment of Anaphylaxis: A Cost-Utility Modeling Approach
Sep 9, 2025, 16:22 PM -
Bayesian Network Meta-Analysis of Weight Loss Efficacy for GLP-1 Receptor Agonists and Tirzepatide
Sep 9, 2025, 16:22 PM -
Mind the Gap: Understanding the Global Imbalances in Spending for Innovative Medicines
Sep 9, 2025, 16:22 PM -
Estimating the Mean Time in Treatment-Free Remission for Patients in Early Line CML
Sep 9, 2025, 16:22 PM -
Confirmation of Diagnosis Method for Robust Participant Selection in Direct-to-Patient Real-World Evidence Studies
Sep 9, 2025, 16:22 PM -
Premature Cancer-Related Morbidity and Mortality in Israel: Years Lived With Disability and Years of Life Lost Productivity Costs
Sep 9, 2025, 16:22 PM -
Eligibility and Strategic Implications of Germany’s 2025 Confidential Pricing Reform
Sep 9, 2025, 16:22 PM -
Health Economic Assessment of Cefepime-Enmetazobactam for Treating Complicated Urinary Tract Infections: A German Payer Perspective
Sep 9, 2025, 16:22 PM
